publication . Article . 2018

Prevalencia de cardiopatía isquémica asintomática en pacientes con diabetes mellitus tipo 2

Yu L. Lee-Tsai; Luis C. Barrios-Lupitou; Dulman O. Pineda-De Paz; Clara Elizabeth Chang; Mario R. Pineda-De Paz; Lissette C. Torres-Salazar;
Open Access English
  • Published: 01 Apr 2018 Journal: Revista Colombiana de Cardiología (issn: 0120-5633, Copyright policy)
  • Publisher: Elsevier
Abstract
Resumen: Introducción: La enfermedad cardiovascular es la causa principal de muerte en pacientes con diabetes mellitus. La prevalencia de cardiopatía isquémica asintomática es más alta en pacientes diabéticos que en no diabéticos y se asocia a peor pronóstico. Objetivo: Identificar la prevalencia de cardiopatía isquémica asintomática en pacientes con diabetes mellitus tipo 2 en un hospital de tercer nivel de atención de Guatemala y analizar la posible asociación de dicha enfermedad con características epidemiológicas, clínicas y metabólicas. Métodos: Estudio de corte transversal en el que se estudió una muestra de 92 pacientes diabéticos seleccionados de forma a...
Subjects
free text keywords: Diseases of the circulatory (Cardiovascular) system, RC666-701, Cardiology and Cardiovascular Medicine, Isquemia miocárdica, Electrocardiografía, Prueba de esfuerzo, Dobutamina, Myocardial ischaemia, Electrocardiograph, Stress test, Dobutamine, Gynecology, medicine.medical_specialty, medicine, Diabetes mellitus, medicine.disease, business.industry, business, Microalbuminuria
Related Organizations
45 references, page 1 of 3

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35 Suppl 1:S64-S71. doi: 10.2337/dc12-s064.

2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137--49, http://dx.doi.org/ 10.1016/j.diabres.2013.11.002 [OpenAIRE]

3. Barceló A, Rajpathak S. Incidence and prevalence of diabetes mellitus in the Americas. Rev Panam salud pu´ıblica=Pan Am J public Heal. 2001;10:300--8, http://dx.doi.org/ 10.1590/S1020-49892001001100002 [OpenAIRE]

4. Aschner P, Aguilar-Salinas C, Aguirre L, Franco L, Gagliardino J, Gorban S, et al. Diabetes in South and Central America: An update. Diabetes Res Clin Pract. 2014;103:238--43, http://dx.doi.org/10.1016/j.diabres.2013.11.010

5. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001:S14--21, http://dx.doi.org/10.1007/PL00002934, 44 Suppl 2(Suppl 2).

6. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio Jr, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245--50, http://dx.doi.org/10.1161/01.CIR. 0000140677.20606.0E

7. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;167:1145--51, http://dx.doi.org/10.1001/archinte.167.11.1145

8. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;11:2--14, http://dx.doi.org/ 10.1161/01.ATV.11.1.2t

9. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937--52, http://dx.doi.org/10.1016/S0140-6736(04)17018-9 [OpenAIRE]

10. Airaksinen KE. Silent coronary artery disease in diabetes-a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia. 2001;44:259--66, http://dx.doi.org/10.1007/s001250051609 [OpenAIRE]

11. Blanchet Deverly A, Amara M, Larifla L, VelayoudomCéphise FL, Roques F, Kangambega P, et al. Silent myocardial ischaemia and risk factors in a diabetic AfroCaribbean population. Diabetes Metab. 2011;37:533--9, http://dx.doi.org/10.1016/j.diabet.2011.05.006

12. Milan Study on Atherosclerosis and Diabetes (MiSAD). Prevalence of Unrecognized Silent Myocardial Ischemia and Its Association With Atherosclerotic Risk Factors in NoninsulinDependent Diabetes Mellitus. Am J Cardiol. 1997; 79(2):134-39. doi:10.1016/S0002-9149(96)00699-6.

13. Miller TD, Rajagopalan N, Hodge DO, Frye RL, Gibbons RJ. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J. 2004;147:890--6, http://dx.doi.org/10.1016/j.ahj.2003.08.015

14. Barthelemy O, Jacqueminet S, Rouzet F, Isnard R, Bouzamondo A, Le Guludec D, et al. Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes. Arch Cardiovasc Dis. 2008;101:539--46, http://dx.doi.org/10.1016/j.acvd.2008.06.015

15. IDF, Diabetes Atlas, Group. Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2013. Diabetes Res Clin Pract. 2015;109:461--5, http://dx.doi.org/10.1016/j.diabres.2015.05.037

45 references, page 1 of 3
Any information missing or wrong?Report an Issue